4,195
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Prediabetes in pregnancy – follow-up, treatment, and outcomes compared to overt pregestational diabetes

, , , , , , & ORCID Icon show all
Article: 2191153 | Received 20 Jan 2023, Accepted 10 Mar 2023, Published online: 21 Mar 2023

References

  • American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl. 1):S17–S38.
  • Cai X, Zhang Y, Li M, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:m2297.
  • Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25(12):2165–2171.
  • Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet. 2009;374(9702):1677–1686.
  • Lindström J, Louheranta A, Mannelin M, et al. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230–3236.
  • Lindström J, Peltonen M, Eriksson JG, et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia. 2013;56(2):284–293.
  • Riskin A, Itzchaki O, Bader D, et al. Perinatal outcomes in infants of mothers with diabetes in pregnancy. Isr Med Assoc J. 2020;22(9):569–575.
  • Stogianni A, Lendahls L, Landin-Olsson M, et al. Obstetric and perinatal outcomes in pregnancies complicated by diabetes, and control pregnancies, in Kronoberg, Sweden. BMC Pregnancy Childbirth. 2019;19(1):159.
  • Osmundson SS, Zhao BS, Kunz L, et al. First trimester hemoglobin A1C prediction of gestational diabetes. Am J Perinatol. 2016;33(10):977–982.
  • Chen L, Pocobelli G, Yu O, et al. Early pregnancy hemoglobin A1C and pregnancy outcomes: a population-based study. Am J Perinatol. 2019;36(10):1045–1053.
  • Fong A, Serra A, Gabby L, et al. Use of hemoglobin A1c as an early predictor of gestational diabetes. Am J Obstet Gynecol. 2014;253(1):S135–S136.
  • Hughes RCE, Moore MP, Gullam JE, et al. An early pregnancy HbA1c ≥5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care. 2014;37(11):2953–2959.
  • Mañé L, Flores-Le Roux JA, Benaiges D, et al. Role of first-trimester HbA1c as a predictor of adverse obstetric outcomes in a multiethnic cohort. J Clin Endocrinol Metab. 2017;102(2):390–397.
  • Mañé L, Flores-Le Roux JA, Pedro-Botet J, et al. Is fasting plasma glucose in early pregnancy a better predictor of adverse obstetric outcomes than glycated haemoglobin? Eur J Obstet Gynecol Reprod Biol. 2019;234:79–84.
  • Rowan JA, Budden A, Sadler LC. Women with a nondiagnostic 75 g glucose tolerance test but elevated HbA1c in pregnancy: an additional group of women with gestational diabetes. Aust N Z J Obstet Gynaecol. 2014;54(2):177–180.
  • Sweeting AN, Ross GP, Hyett J, et al. Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment. Diabetes Care. 2016;39(1):75–81.
  • Quansah DY, Gross J, Gilbert L, et al. Cardiometabolic and mental health in women with early gestational diabetes mellitus: a prospective cohort study. J Clin Endocrinol Metab. 2022;107(3):e996–e1008.
  • Jayasinghe IU, Koralegedara IS, Agampodi SB. Early pregnancy hyperglycaemia as a significant predictor of large for gestational age neonates. Acta Diabetol. 2022;59(4):535–543.
  • Osmundson SS, Norton ME, El-Sayed YY, et al. Early screening and treatment of women with prediabetes: a randomized controlled trial. Am J Perinatol. 2016;33(2):172–179.
  • Hughes RCE, Rowan J, Williman J. Prediabetes in pregnancy, can early intervention improve outcomes? A feasibility study for a parallel randomised clinical trial. BMJ Open. 2018;8(3):e018493.